Boston Scientific
457 hedge funds and large institutions have $15.3B invested in Boston Scientific in 2014 Q2 according to their latest regulatory filings, with 64 funds opening new positions, 135 increasing their positions, 169 reducing their positions, and 41 closing their positions.
67% more call options, than puts
Call options by funds: $31.9M | Put options by funds: $19.1M
56% more first-time investments, than exits
New positions opened: 64 | Existing positions closed: 41
4% more funds holding
Funds holding: 439 → 457 (+18)
3.02% more ownership
Funds ownership: 87.65% → 90.67% (+3%)
2% less capital invested
Capital invested by funds: $15.7B → $15.3B (-$346M)
20% less repeat investments, than reductions
Existing positions increased: 135 | Existing positions reduced: 169
46% less funds holding in top 10
Funds holding in top 10: 13 → 7 (-6)
Top Buyers
| 1 |
JP Morgan Chase
New York
|
+$657M |
| 2 |
Capital World Investors
Los Angeles,
California
|
+$345M |
| 3 |
Norges Bank
Oslo,
Norway
|
+$133M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$86M |
| 5 |
Bank of New York Mellon
New York
|
+$68.8M |
Top Sellers
BSX Hedge Fund Activity: Q2 2014 in Review
457 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q2 2014, worth a combined $15.3B — down 2.2% from $15.7B a quarter earlier.
Buyers outnumbered sellers: 64 funds opened new BSX positions and 41 closed out — a net gain of 23 holders — while 135 added to existing stakes and 169 trimmed.
The largest buyer was JP Morgan Chase, adding an estimated $657M. The largest seller was Fidelity Investments, cutting an estimated $491M.
- 457 institutional investors held Boston Scientific (BSX) as of Q2 2014, up from 439 in Q1 2014.
- Funds reported $15.3B of Boston Scientific stock for Q2 2014, down 2.2% quarter-over-quarter.
- 64 funds opened new Boston Scientific positions in Q2 2014 and 41 closed out, a net change of +23 holders.
- The largest Boston Scientific buyer in Q2 2014 was JP Morgan Chase, an estimated $657M added.
- The largest Boston Scientific seller in Q2 2014 was Fidelity Investments, an estimated $491M sold.
Based on aggregated 13F filings for Q2 2014.